市場調査レポート

商品コード

1623760

血漿交換の市場規模、シェア、成長分析、製品別、技術別、手順別、用途別、エンドユーザー別、地域別 - 産業予測、2025～2032年

Plasmapheresis Market Size, Share, Growth Analysis, By Product (Instruments, Disposables), By Technology (Membrane Filtration, Centrifugation), By Procedure, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日: 2024年12月25日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

血漿交換市場規模は2023年に12億4,000万米ドルと評価され、2024年の13億4,000万米ドルから2032年には24億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.7%で成長する見通しです。

世界の血漿交換産業は、マクロ経済およびミクロ経済のさまざまな要因によって大きな成長を遂げようとしています。特に中東とアジア太平洋地域におけるヘルスケア支出の増加が、先進医療治療への注目度を高めています。さらに、重症筋無力症やループスなどの免疫系疾患に対する治療選択肢に対する意識の高まりが、市場の需要を促進すると予想されます。市場推計・予測では、2022年から2028年にかけて約79bpの成長が見込まれ、CAGR 21.1%で成長すると推定される自己免疫疾患診断薬セクターの35.9%以上を市場が担っています。2021年末にはCAGR 4.6%増の12億米ドルに達し、13億米ドルに達すると予測され、北米が市場をリードしています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

CSL Limited（Australia）
Takeda Pharmaceutical Company Limited（Japan）
Grifols, S.A.（Spain）
Baxter International Inc.（United States）
Kedrion S.p.A.（Italy）
Octapharma AG（Switzerland）
Asahi Kasei Medical Co., Ltd.（Japan）
B. Braun Melsungen AG（Germany）
Fresenius SE & Co. KGaA（Germany）
Terumo BCT, Inc.（United States）
Haemonetics Corporation（United States）
Cerus Corporation（United States）
Nikkiso Co., Ltd.（Japan）
Kawasumi Laboratories, Inc.（Japan）
Macopharma SA（France）
Shanghai RAAS Blood Products Co., Ltd.（China）
China Biologic Products Holdings, Inc.（China）
LFB S.A.（France）
Bio Products Laboratory Ltd.（United Kingdom）
Sanquin Blood Supply Foundation（Netherlands）

結論と推奨事項

Product Code: SQMIG35D2001

Plasmapheresis Market size was valued at USD 1.24 Billion in 2023 and is poised to grow from USD 1.34 Billion in 2024 to USD 2.41 Billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The global plasmapheresis industry is poised for significant growth due to a variety of macroeconomic and microeconomic factors. Increased healthcare spending, particularly in the Middle East and Asia-Pacific regions, is driving a greater focus on advanced medical therapies. Additionally, heightened awareness of treatment options for immune system disorders such as myasthenia gravis and lupus is expected to fuel market demand. Projections indicate a growth of approximately 79 basis points from 2022 to 2028, with the market catering to over 35.9% of the autoimmune disease diagnostics sector, which is estimated to grow at a 21.1% CAGR. The market experienced a 4.6% CAGR increase to reach USD 1.2 billion by the end of 2021 and is anticipated to reach USD 1.3 billion, with North America leading the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Plasmapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Plasmapheresis Market Segmental Analysis

Global Plasmapheresis Market is segmented by product, technology, procedure, application, end user and region. Based on product, the market is segmented into instruments and disposables. Based on technology, the market is segmented into membrane filtration and centrifugation. Based on procedure, the market is segmented into photopheresis, Ldl apheresis, plateletpheresis, leukapheresis and erythrocytapheresis. Based on application, the market is segmented into source plasma collection, therapeutic plasmapheresis, immunology, neurology, hematology, critical care, oncology, rheumatology & orthopedics and other therapeutic applications. Based on end user, the market is segmented into blood banks & plasma collection centers, hospital & clinics, biopharmaceutical companies and other end user. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Plasmapheresis Market

The plasmapheresis market is poised for growth, largely driven by its critical role in managing a range of autoimmune disorders, including thrombotic thrombocytopenic purpura, Guillain-Barre syndrome, Myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. As the prevalence of these conditions rises, so does the demand for plasmapheresis equipment. Additionally, increasing awareness among end-users and a heightened focus on enhancing healthcare infrastructure are anticipated to propel market expansion. The growing healthcare investments in regions such as the Middle East, Africa, and Asia Pacific are further expected to drive the adoption of advanced treatment methods, thereby boosting the plasmapheresis industry during the forecast period.

Restraints in the Plasmapheresis Market

The plasmapheresis market faces certain restraints primarily due to concerns regarding adverse effects associated with the procedure. Although these side effects, which can include decreased arterial blood pressure, arrhythmias, transient increases in body temperature, and paresthesia, are generally mild, they can still deter potential patients from opting for this therapy. Consequently, these safety concerns may hinder the overall adoption of plasmapheresis, impacting its growth in the market. As such, market players could experience challenges during the evaluation period due to a decline in the utilization of plasmapheresis as a viable treatment option, affecting their overall market performance.

Market Trends of the Plasmapheresis Market

The plasmapheresis market is poised for significant growth, fueled by the escalating demand for effective treatments for various ailments including anemia, blood disorders, and autoimmune diseases. Innovations in apheresis technology, driven by advancements in healthcare infrastructure and increased investments in research and development, are enhancing the efficiency and safety of plasmapheresis procedures. Furthermore, the rising awareness of the therapeutic benefits of plasma exchange therapies is catalyzing a surge in blood donation rates. As healthcare organizations focus on optimizing plasmapheresis equipment worldwide, the market is expected to expand robustly in the coming years, driven by these pivotal trends and advancements.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Plasmapheresis Market Size by Product & CAGR (2025-2032)

Market Overview
Instruments
Disposables

Global Plasmapheresis Market Size by Technology & CAGR (2025-2032)

Market Overview
Membrane Filtration
Centrifugation

Global Plasmapheresis Market Size by Procedure & CAGR (2025-2032)

Market Overview
Photopheresis
Ldl Apheresis
Plateletpheresis
Leukapheresis
Erythrocytapheresis

Global Plasmapheresis Market Size by Application & CAGR (2025-2032)

Market Overview
Source Plasma Collection
Therapeutic Plasmapheresis
Immunology
Neurology
Hematology
Critical Care
Oncology
Rheumatology & Orthopedics
Other Therapeutic Applications

Global Plasmapheresis Market Size by End User & CAGR (2025-2032)

Market Overview
Blood Banks & Plasma Collection Centers
Hospital & Clinics
Biopharmaceutical Companies
Other End User

Global Plasmapheresis Market Size & CAGR (2025-2032)

North America (Product, Technology, Procedure, Application, End User)
- US
- Canada
Europe (Product, Technology, Procedure, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technology, Procedure, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technology, Procedure, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technology, Procedure, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

CSL Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kedrion S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Octapharma AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Kasei Medical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo BCT, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haemonetics Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cerus Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nikkiso Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kawasumi Laboratories, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Macopharma SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai RAAS Blood Products Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China Biologic Products Holdings, Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LFB S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Products Laboratory Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanquin Blood Supply Foundation (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

血漿交換の市場規模、シェア、成長分析、製品別、技術別、手順別、用途別、エンドユーザー別、地域別 - 産業予測、2025～2032年

Plasmapheresis Market Size, Share, Growth Analysis, By Product (Instruments, Disposables), By Technology (Membrane Filtration, Centrifugation), By Procedure, By Application, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

血漿交換市場規模：製品別

血漿交換市場規模：技術別

血漿交換市場規模：手順別

血漿交換市場規模：用途別

血漿交換市場規模：エンドユーザー別

血漿交換市場規模